Results of a multicentre UK-wide study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the pre-transplant naive setting

Kim Linton

Results of a multicentre UK-wide study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the pre-transplant naive setting

Kim Linton

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

34 Downloads (Pure)

Original language	English
Journal	Hematological oncology
Volume	35
Issue number	S1
Publication status	Published - 7 Jun 2017

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Eyre_et_al-2017-Hematological_OncologyFinal published version, 112 KB

Cite this

@article{45473ee2fb5b4bbca7269d0a9007fee5,

title = "Results of a multicentre UK-wide study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the pre-transplant naive setting",

author = "Kim Linton",

year = "2017",

month = jun,

day = "7",

language = "English",

volume = "35",

journal = "Hematological oncology",

issn = "1099-1069",

publisher = "John Wiley & Sons Ltd",

number = "S1",

}